Across TCGA pan-cancer cohorts, GK mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated GK data layer compared with 27 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher GK mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GK expression acts as an unfavorable survival marker, although some lineages such as CCRCC and GBM show a favorable association.
CCRCC, LUAD, and PDAC are the cancer types where GK mass-spec protein most reproducibly stratifies survival.